The QualityStocks Daily Tuesday, March 19th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (TECR) +90.91%

PennyStockProphet (TYHT) +84.82%

StockMarketWatch (VXRT) +44.44%

The QualityStocks Daily Stock List

Altamira Gold Corp. (EQTRF)

Capital Equity Review, Stockscores, Spotlight Growth, 4-Traders, StreetWise Reports, Junior Mining Network, Seeking Alpha, Barchart, InvestorX, Stockwatch, MarketWatch, Stockhouse, The Street, GuruFocus, Wallet Investor, and Barchart reported beforehand on Altamira Gold Corp. (EQTRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Altamira Gold Corp. engages in the acquisition, exploration, development, and mining of mineral properties in Canada and Brazil. A junior natural resource enterprise, the Company previously went by the name Equitas Resources Corp. It changed its corporate name to Altamira Gold Corp. in April 2017. Altamira Gold is headquartered in Vancouver, British Columbia and the Company lists on the OTC Markets.

Altamira Gold is concentrating on the exploration and development of gold deposits within the Juruena belt of western Brazil. The Company has a Brazil focus. Altamira has 12 license areas consisting of 200,000-plus ha in the prolific Juruena gold belt (7–10M oz of artisanal gold production).

Altamira Gold also has its advanced Cajueiro Project. This project has an NI 43-101 (National Instrument 43-101) resource of Indicated Resources of 214,000 oz Au and Inferred Resources of 204,000 oz Au plus an additional 79,000 oz at 1.61 g/t Au in oxides (as Saprolite). Two new zones were discovered at the Cajueiro Project in 2017. The two new zones discovered are at Baldo East and Toninho.

In addition, the Company has its Crepori Project. This Project is 8,323 ha with historical small-scale production. The Crepori Project is 105 km SSW of Eldorado Gold’s TZ Project. Surface sampling at Crepori has returned values up to 1022.98 g/t gold with about 10 percent of surface samples returning +5 g/t gold.

Altamira Gold reported this past December that it successfully applied to claim a strategic land position within the Alta Floresta Belt. The new claims total 70,184.70 hectares. They lie on the northern margin of the Alta Floresta Belt close to the contact with the sediments of the Cachimbo Graben. Altamira Gold's total land position in the belt is now more than 300,000 hectares.

In February, Altamira Gold reported that it was granted an additional 42,000ha within the Apiacas district in Brazil, situated close to the northern margin of the Alta Floresta Belt. Highlights include the granting of 42,000ha at Apiacas bringing the total land position controlled by Altamira Gold at Apiacas to 82,000ha. This includes the highly prospective Mutum target characterized by widespread phyllic alteration and disseminated pyrite.

Recent surface sampling by the Company returned gold values ranging from 9.0 to 46.1 g/t gold from 9 grab samples of a total of 17 samples from the Paulinho Troca-Tiro target. Highlights also include recognition of extensive disseminated gold mineralization associated with hydrothermal alteration over several square kilometers at the Mutum target.

Altamira Gold Corp. (EQTRF), closed Tuesday's trading session at $0.0654, even for the day, on 1,000 volume. The average volume for the last 3 months is 31,447 and the stock's 52-week low/high is $0.0413/$0.1978.

chart

Bespoke Extracts, Inc. (BSPK)

Simply Wall St, Stockopedia, InvestorsHub, Wallmine, Stockhouse, Ventureline, GuruFocus, Investors Hangout, Barchart, Wallet Investor, Infront Analytics, YCharts, Market Screener, Morningstar, Market Exclusive, Marketwired, Insider Financial, and MarketWatch reported earlier on Bespoke Extracts, Inc. (BSPK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bespoke Extracts, Inc. is a producer of high quality, flavorful, hemp-derived cannabidiol (CBD) extract products. The Company established in early 2017 to introduce a proprietary line of premium quality, all-natural CBD products in the form of tinctures and capsules for the nutraceutical and veterinary markets. Bespoke Extracts is headquartered in Sunny Isles Beach, Florida. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s products are marketed as dietary supplements and distributed through the Company’s direct-to-consumers e-commerce store. Bespoke’s products are produced using pure, all natural, zero-THC phytocannabinoid-rich (PCR) hemp-derived CBD. CBD is non-psychoactive. CBD (cannabidiol) is one of over 85 cannabinoids found in cannabis. CBD is present in more significant quantities in hemp than it is marijuana.

Bespoke Extracts’ mission is to become one of the world’s most trusted sources for premium quality, all-natural, USA-grown, hemp-derived cannabidiol (CBD) products for the nutraceutical and veterinary markets. The Company strives to use only vegan, Fair Trade Certified, and organic ingredients with fast acting benefits for anyone looking for an alternative remedy. Bespoke’s farmers have been innovators in hemp agriculture, farming practices, agrotech, as well as production for generations. Bespoke’s hemp is stable, high in CBD, low in THC, and resistant to pathogens and pests.

The Company’s products include Sport Lemon Lime Tincture – THC Free 1500MG; CBD Manuka Honey Tincture; and CBD Bacon Flavored Pet Tincture. Moreover, products include CBD Softgel Capsules; CBD Pain Relief Cream; and CBD Isolate Powder.

Bespoke Extracts announced this past November that its Board of Directors appointed Niquana (Nikki) Noel as President and Chief Executive Officer (CEO), effective immediately. Serving Bespoke as its Operations Manager, Noel assumed day-to-day leadership of the Company and joined its Board of Directors. Noel has spent close to two decades working with privately-held and publicly-traded micro and small cap companies.

Bespoke Extracts, Inc. (BSPK), closed Tuesday's trading session at $0.062, down 7.46%, on 54,147 volume with 16 trades. The average volume for the last 3 months is 99,183 and the stock's 52-week low/high is $0.025/$1.769.

chart

DXI Energy, Inc. (DXIEF)

Stockfuse, MarketWatch, InvestorsHub, Zacks, Oilandgas360, Tip Ranks, Wallet Investor, Stock Digest, Amigo Bulls, Dividend Investor, Stockhouse, Private Capital News Wire, Stockwatch, Equity Clock, The Street, Barchart, Marketwired, YCharts, Capital Cube, Street Insider, Marketbeat, ValueForum, and Seeking Alpha reported on DXI Energy, Inc. (DXIEF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

DXI Energy, Inc. is a tactical acquisitor and developer of strategic energy resources. The Company is an upstream oil and gas exploration and production company. DXI Energy operates in Colorado’s Piceance Basin and in the Peace River Arch area in British Columbia (B.C.). DXI Energy has offices in Calgary, Alberta, and Vancouver, British Columbia. The Company’s shares trade on the OTC Markets’ OTCQB.

In Colorado’s Piceance Basin, DXI Energy has 24,407 net acres. In the Peace River Arch area in B.C. it has 13,093 net acres. Concerning its project areas, in the Piceance Basin in northwest Colorado, DXI has its Kokopelli project with 12 producing wells with extensive in place infrastructure to supplement future development as product prices dictate.

The Company’s land holdings in the Piceance Basin highlight potential long-term regional resource value. This is as utilities develop sources of natural gas. For Kokopelli, DXI Energy retains a 25 percent Working Interest (WI) in 2,200 acres (550 net, 2 leases).

In addition, DXI has its Roan Creek project (West Piceance Hi-Pressure Mancos/Niobrara Gas). This project is 1,960 net acres, 100 percent WI. There is potential development of 8-10 high pressure Mancos/Niobrara 8200’ vertical/Hz wells.

The Woodrush Project in northeastern B.C. encompasses 14,444 net acres (20.701 (gross) with 12 wells (3 oil and gas, 9 natural gas). DXI is the operator and it owns 99 percent of the Project. The Company has a multi-phase plan to expand production and landholdings at the Woodrush Project. It has $13mm invested in production facilities and a related network of pipelines at the Woodrush Project.

Earlier this month, DXI Energy announced that it received all B.C. Oil & Gas Commission (BCOGC) permits to begin the drilling of a key Halfway formation exploration well at its Woodrush NE B.C. complex. Contracts for the building of road access and an environmentally modified drill pad meeting specs of all First Nation stakeholders were issued; construction is underway.

Chief Financial Officer, Mr. David Matheson, said, "With the permit to drill from the BCOGC (inclusive of all other stakeholders), we will now test the voracity of the Paradigm 3D seismic imaging and interpretation software with the drilling and completion of this important Woodrush Halfway pool test prior to winter 2019 break up."

DXI Energy, Inc. (DXIEF), closed Tuesday's trading session at $0.05, down 34.98%, on 1,306,709 volume with 53 trades. The average volume for the last 3 months is 122,573 and the stock's 52-week low/high is $0.0104/$0.09.

chart

Freedom Leaf, Inc. (FRLF)

MicroSmallCap, Promotion Stock Secrets, InvestorsHub, OTC Markets, Stockhouse, Penny Stock Tweets, CFN Media Group, SmallCapVoice, Daily Marijuana Observer, and Stocks To Buy Now reported beforehand on Freedom Leaf, Inc. (FRLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Freedom Leaf, Inc. (The Marijuana Legalization Company™) is a group of global, vertically integrated hemp businesses and cannabis media companies. It is a foremost go-to resource in the cannabis, medical marijuana, and industrial hemp industry. The Company is building a varied portfolio of valuable businesses through strategic mergers, acquisitions, and acceleration projects across the industry. Leafceuticals, Inc. is a wholly-owned division of Freedom Leaf. Hempology® is Freedom Leaf’s exclusively branded product line. Freedom Leaf is based in Las Vegas, Nevada.

Freedom Leaf’s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. Freedom Leaf produces a portfolio of news, print, and digital multi-media verticals, websites, and web advertising, for the ever-developing and changing cannabis, medical marijuana, and industrial hemp industry.

Freedom Leaf targets acquisitions of high growth and niche companies. Its strategy is to identify select technology companies and companies that are involved in cannabis and industrial hemp genetics, intellectual property (IP), bioscience, nutraceutical, and pharmaceutical product development. The Company does not handle, grow, sell, or disperse marijuana.

The above-mentioned Hempology® is now vertically integrated from seed to consumer, processing CBD and a whole spectrum of whole-hemp extracts for the entourage-effect. Furthermore, Freedom Leaf has its hemp-based rolling paper company, Plants to Paper.

Moreover, Freedom Leaf has its LaMarihuana.com. This is the Spanish Speaking community's leading cannabis website. Also, Freedom Leaf has its www.Marihuana-Medicinal.com. This is the largest Medical Cannabis information website in Spanish.

Freedom Leaf earlier acquired 100 percent of Green Market Europe S.L. (GME). GME is a Spanish producer of hemp products. Additionally, Freedom Leaf acquired 100 percent of Tierra Science Global, LLC. Tierra specializes in health supplements supporting peak bio-energy levels in humans.

Freedom Leaf has also acquired the Irie CBD Product Line. This includes virtually all assets, trademarks, formulating equipment, formulas and products. Irie is a California-based CBD, "Cannabidiol", product line. In addition, Freedom Leaf is entering the CBD beverage category with the acquisition of Hemp2o Beverage Company.

This past January, Freedom Leaf announced the appointment of Mr. David Vautrin to its Board of Directors. Mr. Vautrin brings invaluable beverage and cannabis expertise to the Board. He has a successful track record in privately held and publicly traded, multi-billion-dollar consumer packaged goods (CPG) companies, and ownership and leadership in mid-cap and emerging growth organizations. He is currently the Vice President of Sales & Marketing at Origin House, (previously known as CannaRoyalty), where he has worked since March 2017.

Mr. Clifford J Perry, Freedom Leaf's Chief Executive Officer, said: "We are very excited that Dave is joining the Freedom Leaf Board. He brings a deep reservoir of experience in CPG sales, marketing and branding that will be invaluable as Freedom Leaf evolves into a leading CBD health and wellness brand provider."

Freedom Leaf, Inc. (FRLF), closed Tuesday's trading session at $0.21, up 0.76%, on 223,881 volume with 58 trades. The average volume for the last 3 months is 530,675 and the stock's 52-week low/high is $0.09/$0.795.

chart

InnerScope Hearing Technologies, Inc. (INND)

Spotlight Growth, Wolf Street, Market Screener, Stockwatch, Stockopedia, Biz Journals, Front Page Stocks, BioSpace, YCharts, OTC Markets, Marketwired, Simply Wall St, Stockhouse, Marketbeat, InvestorsHub, and MarketWatch reported earlier on InnerScope Hearing Technologies, Inc. (INND), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

InnerScope Hearing Technologies, Inc. is a technology driven business with highly scalable B2B (Business-to-Business) and B2C (Business-to-Consumer) solutions. The OTCQB-listed Company has plans to continue opening, acquiring and operating, a chain of audiological and retail hearing device clinics. InnerScope offers a B2B SaaS based Patient Management System (PMS) software program. It will also provide a Buying Group experience for the audiology practice to enable owners to lessen product costs and increase their margins. InnerScope Hearing Technologies has its corporate office in Roseville, California.

InnerScope will create seven separate revenue generating divisions. The Company said that each division will generate revenues and be positioned for growth, increasing InnerScope’s market penetration. The Company will compete in the DTC (Direct-to-Consumer) markets, - “Hearable”, “Wearable”, Personal Sound Amplification Product (PSAP). This will include pioneering APPs on the iOS and android markets that will be solely dedicated to the hearing impairment population around the world.

The ALPHA brand product line will be InnerScope’s first products to be registered as Class-1 FDA-Cleared hearing aid medical devices. This will considerably grow its product portfolio of hearing assistance products and broaden its digital footprint via a multi-direct-to-consumer sales platform.

Recently, InnerScope Hearing Technologies announced a successful "Grand Opening Promotion" for its hearing aid retail location in Fremont, California, located in the San Francisco Bay Area that opened Monday February 11, 2019. Fremont is the Company's sixth audiological hearing aid retail clinic under its dba Value Audiology & Hearing Aid Center brand in California. In addition, InnerScope announced its seventh Retail Clinic with the "Grand Opening" of the Elk Grove, California  location, a suburb of Sacramento, on Tuesday February 19th.

Last week, InnerScope Hearing Technologies announced plans to distribute its own label of CBD Oil (Hemp Extract) a dietary supplement for people who suffer from Tinnitus (ringing in the ears) and Other Hearing Disorders. The Company has also developed and will distribute its own doctor-designed proprietary line of Nutritional Hearing Dietary Supplements to help people with hearing problems maintain the levels of vitamins, minerals and also promoting better cognitive function for age related hearing loss. InnerScope's CBD Oil and its Nutritional Hearing Dietary Supplements is developed and distributed by "InnerScope Hearing Health", which is a newly created division of InnerScope for the development and distribution of Hearing Related Treatments, Therapies, and Nutritional Hearing Dietary Supplements.

Yesterday, InnerScope Hearing announced its continuing month over month record sales growth for 2019 by reporting an increase of 551 percent for the month of February 2019. This increase reflects the total receipts in February 2019 of $125,374 (unaudited) including prepaid hearing aid sales orders, versus $22,753 revenue booked in February of 2018. Additionally, the February 2019 total receipts show an increase of 143 percent over last month record-setting receipts recorded for January 2019.

InnerScope Hearing Technologies, Inc. (INND), closed Tuesday's trading session at $0.04, even for the day, on 474,506 volume with 40 trades. The average volume for the last 3 months is 1,593,197 and the stock's 52-week low/high is $0.006/$0.159.

chart

Northwest Biotherapeutics, Inc. (NWBO)

RedChip, Promotion Stock Secrets, OTC Picks, Wall Street Corner, BUYINS.NET, StockPicksNYC, INO.com Market Report, Wealth Makers, SmallCapVoice, Wealthpire, Cool Penny Stocks, Street Insider, Pure Action Stocks, Pennybuster, The Street, FeedBlitz, All Penny Stocks, Bull Rally, Marketbeat, Investor Place, and Streetwise Reports reported earlier on Northwest Biotherapeutics, Inc. (NWBO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Northwest Biotherapeutics, Inc. is a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers. In the United States and Europe, the Company’s concentration is on developing personalized immunotherapy products, on a cost-effective basis, designed to treat cancers more effectively than contemporary treatments. This is without toxicities of the kind associated with chemotherapies. Northwest Biotherapeutics is based in Bethesda, Maryland and the Company lists on the OTCQB.

Northwest Biotherapeutics has a broad platform technology for DCVax dendritic cell-based vaccines. The Company is working to move ahead with numerous clinical programs, involving DCVax-L and DCVax-Direct. Northwest’s lead program is a 331-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). This trial has completed its enrolment.

The Company is pursuing completion of the current Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer and pursuing Phase II combination trials of DCVax-L and checkpoint inhibitor drugs. This includes the Phase II trial of DCVax-L and Pembrolizumab (Keytruda) for colon cancer that was previously announced.

Northwest’s product candidates also include DCVax-Prostate. The design of this product is specifically for late stage, hormone independent prostate cancer. The Company has developed a DCVax product line using a particular proprietary antigen — PSMA (Prostate Specific Membrane Antigen). The PSMA is produced via recombinant manufacturing methods. It is subsequently combined with the fresh, personalized dendritic cells to make DCVax-Prostate.

Northwest Biotherapeutics received clearance from the Food and Drug Administration (FDA) for a 612-patient Phase III trial in prostate cancer. It received approval in Germany of a five-year Hospital Exemption for the treatment of all gliomas (primary brain cancers) outside the clinical trial. It is also pursuing a Phase I/II trial with DCVax-Direct for all types of inoperable solid tumor cancers. It completed the 40-patient Phase I portion of the trial. Northwest is preparing for Phase II portions.

Last month, Northwest Biotherapeutics announced that it hired Mr. David Innes as Vice President, Investor Relations. Mr. Innes comes to the Company with more than 31 years of managing portfolios at major Wall Street firms, and a degree in biology.

Mr. Innes said, "After decades of focusing on small to mid-cap biotech and biomedical companies, I was attracted to NW Bio by what I believe is their broad potential, due to their approach to addressing the complexity of solid tumors which comprise most cancers. Their DCVax technology is precision-tailored to a patient's cancer, while also designed to mobilize a broad-spectrum attack on the cancer. As such, I believe NW Bio's DCVax technology has the potential to be a meaningful therapy for many types of solid tumor cancers."

Northwest Biotherapeutics, Inc. (NWBO), closed Tuesday's trading session at $0.318, down 0.63%, on 1,201,107 volume with 171 trades. The average volume for the last 3 months is 1,021,647 and the stock's 52-week low/high is $0.17/$0.35.

chart

Torex Gold Resources, Inc. (TORXF)

Hotstocked, Resource World, Emerging Growth, Market Screener, Barchart, 4-Traders, Northern Vertex, The Assay, Penny Stock Tweets, World Trading Data, Stockhouse, Capital Cube, YCharts, Midas Letter, Marketbeat, Mining Stock Valuator, Tip Ranks, Dividend Investor, Northern Miner, InvestorsHub, and Wallet Investor reported previously on Torex Gold Resources, Inc. (TORXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Torex Gold Resources, Inc. engages in the exploration, development, and operation of mineral properties. The Company explores for gold, silver, and copper deposits. It engages in the exploration, development and operation of its 100 percent owned Morelos Gold Property. This Property is in an area of 29,000 hectares in the highly prospective Guerrero Gold Belt located 180 kilometers southwest of Mexico City. An intermediate gold producer, Torex Gold Resources is based in Toronto, Ontario and its shares trade on the OTC Markets.

Torex’s main assets include the El Limón Guajes Mining Complex, consisting of the El Limón, Guajes and El Limón Sur open pits, the El Limón Guajes underground mine including zones referred to as Sub-Sill, El Limón
Deep, and the processing plant and related infrastructure that started commercial production in April 2016.

The Company’s main assets additionally include the Media Luna Deposit, an early stage development project, and for which Torex issued a Preliminary Economic Assessment (PEA) in 2015. This property remains 75 percent unexplored.

El Limon-Guajes is Torex Gold Resources’ first Mine. The El Limon-Guajes Mine (ELG), situated north of the Balsas River, constitutes one of the richest open pit gold deposits at a resource grade of 2.65 g/t. The Mine commenced gold production in December 2015. On March 30, 2016, it announced commercial production. Upon being in full production, the Mine will be among the largest and lowest cost gold mines globally with expected LOM average annual production of 370,000 ounces of gold at a LOM AISC (All in Sustaining Cost) of US$616/oz.

The Media Luna deposit is hosted in a magnetic anomaly south of the Balsas River. It was discovered in March 2012. It has current Inferred Resources of 7.4 million gold equivalent ounces at a grade of 4.48 g/t. The resource is contained in less than 30 percent of the area of the targeted magnetic anomalies. The conceptual design contained in a positive PEA (Preliminary Economic Assessment) announced in July 2015 anticipates an underground operation with expected average annual production of 313,000 ounces of gold equivalent at an average AISC of US$636/oz.

Recently, Torex Gold Resources reported its financial and operational results for the year ended December 31, 2018. Highlights include record gold production at the top end of guidance of 353,947 ounces. Gold production in the quarter totaled 96,316 ounces. Mine production in the quarter totaled 11,299 kt, averaged 122,815 tpd. Mine production for the year totaled 32,625 kt, averaged 93,214 tpd.

Mine ore production in the quarter totaled 1,234 kt, averaged 13,413 tpd. Mine ore production for the year totaled 4,329 kt, averaged 12,368 tpd. In addition, grade mined in the quarter averaged 2.76 gpt, and 2.69 gpt for the year. Grade processed in the quarter averaged 2.93 gpt and 2.97 gpt for the year.

Furthermore, plant throughput continued to fast-track in the quarter attaining 1,197 kt, averaged 13,011 tpd. Plant throughput in the year of 4,152 kt, averaged 11,863 tpd. Also, gold recovery averaged 85 percent in the quarter and 87 percent in the year, which was consistent with the Company’s design expectations.

Torex Gold Resources, Inc. (TORXF), closed Tuesday's trading session at $13.2508, up 1.54%, on 31,025 volume with 43 trades. The average volume for the last 3 months is 9,025 and the stock's 52-week low/high is $5.73/$13.48.

chart

Bitcoin Investment Trust (GBTC)

Stock Twits, Zacks, CryptoCurrencyFacts, Stock Investor, Street Insider, Strategic Coin, Investopedia, Morningstar, MarketWatch, SlashGear, Stockhouse, Finance Registrar, TradingView, Bitcointalk, The Street, Business Insider, Investor Place, MintDice, Wallet Investor, Brave New Coin, and Cointelegraph reported on Bitcoin Investment Trust (GBTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Grayscale Investments, LLC is an authority on digital currency investing. The Company provides secure access to the digital currency asset class by way of its single-asset and diversified investment products. These include Bitcoin Investment Trust™ (GBTC) and Digital Large Cap Fund™. Formed in 2013 by Digital Currency Group, Grayscale Investments is headquartered in New York, New York. The Company lists on the OTC Markets Group’s OTCQX.

Bitcoin Investment Trust™ is a privately offered trust. It is available solely to accredited investors. Bitcoin Investment Trust’s investment goal is for the value of its shares to reflect the price performance of bitcoin, minus fees and expenses. Bitcoin Investment Trust was established for investors looking for exposure to bitcoin via a traditional investment vehicle.

Bitcoin Cash Investment Trust™ is a privately offered trust. It is available exclusively to accredited investors. Bitcoin Cash Investment Trust’s investment goal is for the value of its shares to reflect the price performance of Bitcoin Cash (BCH), minus fees and expenses. Bitcoin Cash Investment Trust was established for investors looking for exposure to BCH through a traditional investment vehicle.

Last week, Grayscale Investments announced the launch of Zen Investment Trust. This is a single-asset investment vehicle solely consisting of ZEN, a privacy-focused digital currency.

Zen Investment Trust is the eighth single-asset investment product introduced by Grayscale. In addition, it is the first security solely invested in ZEN. Further to its single-asset products, Grayscale Investments also manages the above-mentioned Digital Large Cap Fund™. This is a diversified investment product, which provides exposure to the leading digital currencies by market capitalization.

ZEN is a privacy-oriented digital currency. It is native to Horizen (previously ZenCash), a decentralized technology platform that provides users with total control of their digital footprint.

Mr. Michael Sonnenshein, Managing Director of Grayscale Investments, said, "We've been very impressed with the Horizen team and its vision for ZEN as a leading privacy coin. Grayscale is at the forefront of asset management in this emerging industry, and we will continue to offer our clients access to the most interesting blockchain projects in the world."

Bitcoin Investment Trust (GBTC), closed Tuesday's trading session at $4.99, up 2.25%, on 2,987,658 volume with 2,746 trades. The average volume for the last 3 months is 2,049,596 and the stock's 52-week low/high is $3.66/$16.88.

chart

Kutcho Copper Corp. (KCCFF)

Mining & Energy, Stock Orange, Resource World, Dividend Investor, Stockhouse, Stockwatch, InvestorX, OTC Markets, Resource Stock Digest, Market Screener, 4-Traders, Stateside Report, Junior Mining Network, Junior Stock Review, Investors Hangout, The Prospector News, MarketWatch, Barchart, and Wallet Investor reported on Kutcho Copper Corp. (KCCFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A resource development company, Kutcho Copper Corp. concentrates on expanding and developing the Kutcho high grade copper-zinc project in northern British Columbia. Its intention is to progress the Kutcho Project through feasibility and permitting to a positive construction decision. Kutcho Copper lists on the OTC Markets. The Company has its headquarters in Vancouver, British Columbia (B.C.).

The Kutcho Copper Project is the Company’s 100 percent owned high grade copper-zinc development project situated in northern B.C. It is in a top tier mining jurisdiction with major mines and permitted projects in Tahltan and Kaska territories. Kutcho has a Probable Reserve of 10.4 Mt grading 2.01% Cu and
3.19% Zn (2.92% CuEq).

The Kutcho Copper Project has a Mine Life of 12 years. Its Production Rate is 2,500 tpd. The Project has low risk potential to increase Mineral Reserves
and substantially increase production capacity.

The Wheaton Precious Metals stream establishes a foundation for a strong partnership and lessens financial risk of the Project. There is also the potential for more discoveries via exploration. The Company’s objective is to increase reserves from the present 10.4 Mt through existing resource conversion.

This past July, Kutcho Copper announced it launched MineHub Technologies, Inc. with a syndicate of industry partners. This includes a senior mining company, one of the world’s largest streaming companies, a global base and precious metals and concentrates trading company and an international financial institution offering banking services in the metals and mining industry. MineHub is a leading-edge technology company taking advantage of blockchain technology to develop a new generation of applications for the metals and mining industry.

Recently, Kutcho Copper announced it received from Wheaton Precious Metals Corp. its second advance payment in the amount of US$3.5 million under the Precious Metals Purchase Agreement (PMPA) announced on August 10, 2017. The PMPA entitled Kutcho Copper to a total of US$7 million, which it has now fully received, to finance expenditures related to completing its Feasibility Study (FS).

Kutcho Copper also recently announced initial drill results from the Esso deposit at its Kutcho high grade copper-zinc project and enters into the mineral resource expansion drilling phase of the 2018 field program. Drill hole KC18-038-W1 returned 28m of 2.09% Cu, 6.1% Zn, 65.8 g/t Ag and 0.82 g/t Au or a CuEq of 5.7%. This includes a 10.4m huge sulphide intersection of 3.80% Cu, 14.4% Zn, 134.6g/t Ag and 1.84g/t Au or a CuEq of 12%.

Mr. Vince Sorace, Kutcho Copper President & Chief Executive Officer, stated, “We have now moved into an exciting phase of the field program as the mineral resource expansion drilling at Kutcho is now in full swing and we anticipate releasing drill results frequently over the course of the next few months. The initial drill holes from Esso represent the unique high-grade opportunity achievable at the Kutcho project.”

Kutcho Copper Corp. (KCCFF), closed Tuesday's trading session at $0.2533, up 0.80%, on 43,299 volume with 8 trades. The average volume for the last 3 months is 34,010 and the stock's 52-week low/high is $0.143/$0.497.

chart

Select Sands Corp. (SLSDF)

Zacks, Penny Stock Tweets, Investors Hangout, Wallet Investors, Wall Street Analyzer, Investopedia, Stock Gumshoe, Amigo Bulls, TipRanks, YCharts, Marketbeat, The Street, InvestorsHub, Stockhouse, TradingView, MarketWatch, Simply Wall St, Marketwired, Barchart, OTC Markets, and Penny Stock Hub reported on Select Sands Corp. (SLSDF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Select Sands Corp. is an industrial Silica Product company headquartered in Vancouver, British Columbia. The Company is developing its 100 percent owned, 520-acre Northern White, Tier-1, silica sands project situated in the State of Arkansas. The Company formerly went by the name La Ronge Gold Corp. It changed its name to Select Sands Corp. in November 2014. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Silica Sand is quartz that over time, through the work of water and wind, has been broken down into tiny granules. Commercial Silica Sand is widely used as a proppant by oil and gas companies. In addition, it is used in industrial processing. Whole Grain and Ground Silica products range in size, distributions, grain shapes, and chemical purity.

The Company’s Sandtown project has NI 43-101 (National Instrument 43-101) compliant Indicated Mineral Resources of 42.0MM tons (TetraTech Report; February 2016). Bell Farm has Inferred Mineral Resources of 49.6MM tons (Kleinfelder Report; April 2017). Both deposits are considered Northern White finer-grade sand deposits of 40-70 Mesh and 100 Mesh.

Select Sands has its Ozark Operations in Arkansas. This property is underlain by the Ordovician St. Peter sandstone formation, the source of first-rate industrial silica sand ‘Ottawa White’ frac sand.

Select Sands entered into a binding Letter of Agreement for an option to acquire a 100 percent undivided right, title, and interest in the approximately 520-acre premium grade industrial silica sand/frac sand project in northeast Arkansas. The Arkansas project is strategically located to supply sand to major U.S. oil & gas and Industrial & Specialty markets.

On April 4, 2018, Select Sands exercised an option to purchase 223 acres of property in Independence County, Arkansas (Independence Property). This is to serve as a platform to support the Company’s expansion initiatives.

Select Sands provided 2018 Q2 frac and industrial sand sales volumes guidance of 130,000 to 150,000 tons (press release dated May 18, 2018). Actual tons sold during the period were roughly 165,000 tons, transported by truck, rail and barge. Therefore, frac and industrial sand sales volumes for the 2018 Q2 were a record for the Company.

Select Sands announced last month that it sold a record 164,872 tons of frac and industrial sand during Q2 of 2018. This was considerably higher than the Company’s original outlook for the sale of 120,000 to 140,000 tons. Increased sales volumes and pricing increased Revenue to $9.5 million. This is 68 percent higher than Q1 2018 revenue of $5.7 million.

Select Sands reported record Net Income of $1.6 million in Q2 2018, or $0.02 per basic and diluted common share. This is in comparison to Q1 2018 Net Income of $0.6 million, or $0.01 per basic and diluted common share.

Select Sands Corp. (SLSDF), closed Tuesday's trading session at $0.063, up 3.11%, on 137,650 volume with 2 trades. The average volume for the last 3 months is 43,898 and the stock's 52-week low/high is $0.039/$0.385.

chart

TechCare Corp. (TECR)

InvestorsHub, Barchart, Stockhouse, OTC Markets, Investing, 4-Traders, GuruFocus, PennyStockTweets, Investors Hangout, and Emerging Growth reported on TechCare Corp. (TECR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

TechCare Corp. has a unique delivery platform, which uses vapor technology for natural health and beauty treatments. The Company engages in the design, development, and commercialization of this inventive delivery platform using vaporization of different natural, plant-based compounds, to enable a broad array of treatment solutions. A technology enterprise, TechCare is headquartered in New York, New York. The Company lists on the OTC Markets Group’s OTCQB.

TechCare has a strategic partnership agreement with HoMedics, one of the world's foremost brands in health and wellness products. HoMedics will manufacture, market, and distribute TechCare's Novokid products in the U.S., Canada, Brazil, Argentina, Colombia, and Costa Rica. The products will be co-branded as HoMedics products powered by TechCare.

Novokid consists of a portable device that vaporizes TechCare's all-natural, plant-based solution contained in a disposable capsule. It comes with a proprietary head cap. Novokid is the first of its kind home use device. It presents a scientifically proven solution to eliminate lice, super lice, and eggs.

Novokid is 100 percent natural, plant-based and pesticide-free. Novokid utilizes a proprietary vapor-based delivery platform. TechCare’s Novokid has received CE Mark approval as a CLASS I Medical Device. Novokid uses a simple 10-minute dry treatment. The treatment requires no rinsing or washing and is quick, dry, and clean. It is easily administered at home or while mobile. Moreover, Novokid can be used as a maintenance and preventative treatment if used regularly.

At the end of May 2018, TechCare announced that following intensive R&D and investments, it expanded its existing IP portfolio with a recently submitted patent application of its Smart Capsule™ technology. Building upon its existing patents and knowledge, the new Smart Capsule™ technology enables the vaporization of two or more compounds at the same time. Therefore, this expands the range of applications while yielding superior performance, usability and ease-of-use.

TechCare Corp. (TECR), closed Tuesday's trading session at $0.21, up 90.91%, on 38,543 volume with 18 trades. The average volume for the last 3 months is 7,409 and the stock's 52-week low/high is $0.0401/$0.75.

chart

Zynex, Inc. (ZYXI)

Zacks, FeedBlitz, SmallCapVoice, Daily Markets, SmarTrend Newsletters, BUYINS.NET, FNNO Newsletters, and TaglichBrothers reported earlier on Zynex, Inc. (ZYXI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Zynex, Inc. is a medical technology company listed on the OTC Markets Group’s OTCQB. It specializes in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring. In addition, it is developing a new blood volume monitor (non-invasive Blood Volume Monitor, CM-1500) for use in hospitals and surgery centers. Zynex has its corporate office in Englewood, Colorado.

The Company’s product lines are completely developed, Food and Drug Administration (FDA)-cleared, and commercially sold worldwide. Zynex engineers, manufactures, markets, and sells its own design of medical devices in three subsidiaries. Zynex believes that its non-invasive Blood Volume Monitor, CM-1500, will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery.

Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets. Zynex Medical is a provider of electrotherapy products for home use.

Zynex markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation. Additionally, it markets and sells its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. The design of the NeuroMove™ device is to assist stroke survivors in regaining movement using the brain's ability to rewire itself, also known as "neuro-plasticity".

New products in the Company’s portfolio include JetStream Hot/Cold Therapy, Aspen LSO Backbracing and Comfortrac cervical traction. All of these products are aimed at treating acute and chronic pain without side-effects.

Recently, Zynex reported financial results for its Q2 ended June 30, 2018.

Mr. Thomas Sandgaard, Chief Executive Officer, said: "I am pleased to report revenue of $7.6 million in the second quarter with net income of $2.4 million or $0.07 per diluted share. Adjusted EBITDA was $2.8 million and the quarterly revenue was 50% higher than the revenue of the second quarter of 2017. Revenue was up 10% from the $6.9 million recorded in the first quarter of 2018. Orders grew 29% compared to the second quarter 2017 and were 2% higher than the first quarter of 2018. Our cash on hand grew to $6.3 million at the end of the second quarter.”

Zynex, Inc. (ZYXI), closed Tuesday's trading session at $4.40, up 1.15%, on 65,221 volume with 207 trades. The average volume for the last 3 months is 39,303 and the stock's 52-week low/high is $2.40/$5.90.

chart

Vitality Biopharma, Inc. (VBIO)

Penny Stock Tweets, Zacks, The OTC Reporter, Finance Registrar, MarketWatch, GuruFocus, Stock Beast, SmallCap Network, Stockhouse, and Promotion Stock Secrets reported earlier on Vitality Biopharma, Inc. (VBIO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Vitality Biopharma, Inc.’s dedication is to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. Since 2012, the Company has developed a unique capability to produce molecules via glycosylation. This is a form of enzymatic biosynthesis, which was originally developed to improve the taste of stevia. The platform is well suited for the discovery of new pharmaceutical products. OTCQB-listed, Vitality Biopharma has its headquarters in Los Angeles, California.

Late in 2015, Vitality successfully modified cannabidiol (CBD), which is not psychoactive. In continuing work, the Company has created a novel class of pharmaceuticals called cannabosides. Cannabosides, upon ingestion, can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract.

Vitality Biopharma can biosynthesize cannabinoid glycosides (cannabosides) via enzyme biosynthesis. The Company is one of only a very few groups in the world who know how to produce and work with the enzymes that perform glycosylation. It has been focused on it because the same enzymes are used to modify the taste of stevia (steviol glycosides).

Vitality Biopharma has developed a proprietary biosynthesis technology that can modify cannabinoids to create pharmaceutical prodrugs that have no psychoactivity and that can provide targeted disease treatment. The process involves small molecule glycosylation, where sugar molecules are attached to cannabinoids, creating new compounds called cannabinoid glycosides, or cannabosides.

The Company has introduced its lead cannabinoid drug formulation VITA-100 as a non-psychoactive prodrug of THC. Vitality is centering initial clinical development efforts on VITA-100, a proprietary THC cannabinoid drug formulation. The treatment indications it plans to evaluate in Phase 2 trials include inflammatory bowel disease (IBD), irritable bowel syndrome, and narcotic bowel syndrome (a severe form of opiate-induced abdominal pain).

Vitality Biopharma announced in April 2018 the pending establishment of a wholly-owned Canadian subsidiary, Vitality Genetics, Ltd. This subsidiary will focus on and enable the performance of a wide assortment of cannabinoid genetics research and development (R&D) programs.

Vitality Biopharma announced in May the discovery of new antimicrobial activity of cannabinoids and its application for treatment of C. difficile-associated diarrhea and colitis. In experiments executed according to guidance by the Clinical Laboratory and Standards Institute (CLSI), Vitality determined that cannabinoids (including THC) are effective antibiotics for C. diff, VRE, and a variety of additional pathogens.

Recently, Vitality Biopharma announced that during a recent in vitro safety pharmacological screening study, its lead drug candidate VBX-100 demonstrated no signs of adverse pharmacological effects. This affirms its potential for extensive clinical use as a GI-targeted prodrug of THC. Vitality Biopharma has filed for intellectual property (IP) protection on greater than 100 different glycoside prodrugs. This includes VBX-100.

Vitality Biopharma, Inc. (VBIO), closed Tuesday's trading session at $0.50, up 11.11%, on 39,353 volume with 25 trades. The average volume for the last 3 months is 25,326 and the stock's 52-week low/high is $1.05/$2.37.

chart

Alacer Gold Corp. (ALIAF)

Silverstocker, InvestorPlace, Gold Stock Data, Northern Miner, 4-Traders, Investopedia, OTC Markets, MarketWatch, TradingView, Investing, The Street, Mining Feeds, Information Vine, and Penny Stock Tweets reported on Alacer Gold Corp. (ALIAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Alacer Gold Corp. is a leading intermediate gold mining company whose shares trade on the OTC Markets. The Company has an 80 percent interest in the world-class Çöpler Gold Mine in Turkey operated by Anagold Madencilik Sanayi ve Ticaret A.S. The remaining 20 percent is owned by Lidya Madencilik Sanayi ve Ticaret A.S.  Alacer Gold is pursuing initiatives to enhance value beyond the current mine plan. Alacer Gold has its corporate headquarters in Denver, Colorado.

Alacer’s principal focus is to leverage its cornerstone Çöpler Mine and strong balance sheet to maximize portfolio value, maximize free cash flow, and minimize project risk. The Çöpler Mine is situated in east-central Turkey in the Erzincan Province.

Çöpler has substantial Probable Reserves of 4 million recoverable ounces and Measured and Indicated Resources of 6 million ounces of contained gold. These provide the basis for Çöpler’s 20-year mine life. Currently, the Mine is an open-pit, heap-leach operation producing low-cost gold from oxide ore. Over the life of the current heap-leach project, about 76 percent of the gold contained in the oxide ore is expected to be recovered.

Alacer Gold’s Board of Directors approved full construction of the Sulfide Project at the Çöpler Gold Mine in May 2016. The Çöpler orebody contains refractory sulfide ore. This requires a different processing solution than heap-leaching to extract the gold.

The expectation is that the Sulfide Project will deliver long-term growth with good financial returns and adds 20 years of production at the Çöpler Gold Mine. The Sulfide Project capital cost estimate has been decreased from $744 million to $673 million.

Recently, Alacer Gold announced the processing of the first oxide ore through the crushing and grinding circuit over the past weekend. The rest of the plant, including the acidulation, pressure oxidation and counter current decantation circuits (the Sulfide Circuit), will start once the Sulfide Circuit commissioning is complete and the oxide circuit is completely operational and stabilized.

Alacer Gold also recently announced additional positive drilling results at Ardich within the Çöpler District in a press release entitled “Alacer Gold Announces Additional Positive Drill Results for the Ardich Gold Prospect, including 50.2 Meters at 3.01 Grams per Tonne Gold Near Surface”

Alacer Gold Corp. (ALIAF), closed Tuesday's trading session at $2.86, up 3.62%, on 5,998 volume with 12 trades. The average volume for the last 3 months is 21,621 and the stock's 52-week low/high is $1.53/$2.94.

chart

The QualityStocks Company Corner

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Youngevity International, Inc. (NASDAQ: YGYI), a client of CNW and emerging conglomerate operating in three distinct business segments including a vertically integrated coffee enterprise, a vertically integrated Hemp based product development enterprise including end to end processing, and a Direct Selling Enterprise. To view the full publication, titled “Drink Companies Prepare for the Coming of CBD Beverages,” visit: http://cnw.fm/k6IzG.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.69, up 4.21%, on 109,545 volume with 707 trades. The average volume for the last 3 months is 219,825 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

CannabisNewsWire released a report today highlighting The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), which examines how, following the passing of the 2018 Farm Bill, CBD sales have continued their massive growth in the United States and beyond. Also today, the company was highlighted by Pot Stock News due to attractive share price performance.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $4.12, up 7.85%, on 4,616,103 volume with 6,928 trades. The average volume for the last 3 months is 1,221,678 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Innovative biotechnology company Earth Science Tech (OTCQB: ETST) is currently seeking a dual listing of its common shares on the Canadian Securities Exchange (“CSE”). A recent article discussing the company reads, “In addition, ETST has engaged consultant Derek Lindsay to manage compliance while the company moves toward dual listing (http://nnw.fm/a3vQc). To view the full article, visit: http://nnw.fm/aIy7v.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.7105, up 4.55%, on 20,964 volume with 24 trades. The average volume for the last 3 months is 32,271 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Leading telecommunications engineering and infrastructure services provider Spectrum Global Solutions (OTCQB: SGSI) holds a strategic position to enable the buildup of 5G networks as providers rollout their options for service. To view the full article, visit: http://nnw.fm/IJg5k.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.193, up 0.52%, on 69,901 volume with 30 trades. The average volume for the last 3 months is 99,664 and the stock's 52-week low/high is $0.071/$2.59.

Recent News

chart

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

Global Payout Inc. (OTCPINK: GOHE) (“Global”) and its wholly-owned subsidiary MTrac Tech Corporation (“MTrac”) are pleased to announce that transactional data and revenue into Q1 of 2019 highlights the continued growth, adaptation, and overall benefit to the one-of-kind MTrac Payment Solution.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.0057, up 5.56%, on 3,653,728 volume with 100 trades. The average volume for the last 3 months is 6,579,119 and the stock's 52-week low/high is $0.0041/$0.0315.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) was featured today in the 420 with CNW by CannabisNewsWire. When Minnesota legalized medical cannabis in 2014, a task force was established to evaluate the medical cannabis program and report back to the state. However, numerous complaints about the operation and effectiveness of this task force have arisen.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.165205, even for the day, on 8,499 volume. The average volume for the last 3 months is 416 and the stock's 52-week low/high is $0.10/$0.505.

Recent News

chart

Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy (ZNGY), the nation's leading next-generation utility, announced today that their CEO, Alex Rodriguez, will participate in the CEO Roundtable hosted and produced by Energy Marketing Conferences (EMC). EMC is renowned, widely respected and is responsible for the largest and most effective industry events of the year. Zenergy is proud and honored to participate in this event, which is to be held in Houston, TX on April 2, 2019.

Zenergy Brands, Inc. (ZNGY) is a leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. The company’s vision is to converge smart controls (building automation) with energy conservation and retail energy to deliver comprehensive smart-energy service to customers. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions, and improve their bottom line.

The company’s cutting-edge Zero Cost Program™ reduces utility consumption by 20 to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to commercial, industrial, and municipal end-use customers. This financing mechanism allows customers to reduce water, natural gas, and electricity consumption by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program enriches businesses by immediately reducing energy consumption using smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management, and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) permits Zenergy to retain a portion of these utility savings in exchange for financing the upgraded, retrofit equipment, and installation costs until a specified and agreed upon repayment period with the client ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 and 45 percent of total utility costs.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production.

According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025, which is where Zenergy will focus its efforts in 2019 and beyond. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0001, even for the day, on 12,010,530 volume with 11 trades. The average volume for the last 3 months is 112,835,025 and the stock's 52-week low/high is $0.000009/$0.013.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) was highlighted today in a publication from Investorideas.com, examining the future of cannabis sales as companies focus on next-gen tech and e-commerce platforms.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $4.42, off by 0.90%, on 409,119 volume with 1,041 trades. The average volume for the last 3 months is 612,766 and the stock's 52-week low/high is $2.40/$11.82.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted today in a report by CannabisNewsWire looking at how, following the passing of the 2018 Farm Bill, CBD sales have continued their massive growth in the United States and beyond. Also today, the company was highlighted in a report by Livemoney which explains that the CBD retail boom is upon us. As cannabis-infused products find their way into major retailers, analysts believe the trend will provide a significant catalyst.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.64, off by 4.21%, on 230,985 volume with 465 trades. The average volume for the last 3 months is 210,061 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with Genprex Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer. NNW’s Stuart Smith introduces Genprex CEO and Chairman Rodney Varner, JD, for a compelling discussion on the company’s initial product candidate, Oncoprex(TM), an immunogene therapy for non-small cell lung cancer (NSCLC). The interview can be heard at http://nnw.fm/QUUu0.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (OTC: GNPX), closed the day's trading session at $1.99, off by 4.33%, on 92,555 volume with 355 trades. The average volume for the last 3 months is 45,468 and the stock's 52-week low/high is $0.95/$19.45.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

SmallCapVoice.com, Inc. and Nightfood Holdings, Inc. (OTC QB: NGTF), a pioneering consumer goods brand development company that owns both Nightfood, Inc. and MJ Munchies Inc., announced today that the Company is featured in a new audio interview at SmallCapVoice.com, Inc. The interview is available online at http://nnw.fm/N29Ur. Also today, the company was highlighted in the Venture Breakfast Bits, by 24/7 Market News.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed the day's trading session at $0.64425, off by 16.86%, on 1,339,489 volume with 513 trades. The average volume for the last 3 months is 498,608 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) was highlighted today in a publication from Investorideas.com, examining the future of cannabis sales, as companies focus on next-gen tech and e-commerce platforms.

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.5439, off by 1.09%, on 1,178,222 volume with 507 trades. The average volume for the last 3 months is 486,664 and the stock's 52-week low/high is $0.285/$1.129.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Following the passing of the 2018 Farm Bill, CBD sales have continued their massive growth in the United States and beyond. Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is among the companies benefiting from this market, with an increase of more than 300 percent in online sales for its CBD products last year.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.46395, off by 4.34%, on 15,584 volume with 25 trades. The average volume for the last 3 months is 14,206 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

The growth of the hemp sector is having a beneficial effect for both hemp companies and hydroponic suppliers. Sugarmade Inc. (OTCQB: SGMD) via its pending acquisitions is poised to accelerate its growth rate as a result of this hemp cultivation boom, along with other leading companies.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.032, off by 5.88%, on 4,136,196 volume with 260 trades. The average volume for the last 3 months is 7,656,739 and the stock's 52-week low/high is $0.0132/$0.415.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.